Health ❯ Healthcare

Patient Outcomes

Survival Rates Quality of Life Treatment Efficacy Mortality Rates Progression-Free Survival Adverse Events Weight Loss Weight Management Efficacy Studies Disease-Free Survival

5 ARTICLES

3w ago

KRAS Vaccine Elicits Durable Immune Response and Is Well Tolerated in High‑Risk Pancreatic Cohort

Investigators say the phase 1 immune results justify tissue-based follow-up studies and larger trials to test whether vaccination can prevent pancreatic cancer.

4 ARTICLES

4w ago

Selected Lung Transplants Linked to Higher One-Year Survival in Stage 4 Lung Cancer

4 ARTICLES

4w ago

ResMed Agrees to Sell MatrixCare to Frazier Healthcare Partners

3 ARTICLES

last mo.

Dual‑Mobility Hip Cups Cut Dislocation Risk by 70% in Large Randomized Trial

3 ARTICLES

last mo.

Can‑Fite Reports Safe Phase 2a Readout and Survival Signals for Namodenoson in Advanced Pancreatic Cancer

4 ARTICLES

last mo.

Resorbable‑Microsphere Embolization Cuts Knee Osteoarthritis Pain for a Year

5 ARTICLES

last mo.

Meta-Analysis Finds Tirzepatide Produces Largest Average Weight Loss Among FDA‑Approved GLP‑1s

6 ARTICLES

last mo.

Remote Monitoring Fails to Cut Readmissions After Sepsis and Raises Risk for Older Adults

5 ARTICLES

last mo.

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

4 ARTICLES

last mo.

UC Study Links Some Antibody‑Drug Conjugates to High Rates of Severe Neutropenia

12 ARTICLES

2mo ago

Ivonescimab Extends Survival in China Phase 3 Trial for Squamous Lung Cancer

5 ARTICLES

2mo ago

Erleada Plus Hormone Therapy Cuts Recurrence and Death in High‑Risk Localized Prostate Cancer

5 ARTICLES

2mo ago

Implanted Cesium-131 Tiles Cut Recurrences and Boost Survival in ROADS Phase III Trial

6 ARTICLES

2mo ago

NHS‑Backed Trial of Galleri Blood Test Fails to Meet Main Goal

3 ARTICLES

2mo ago

Saitama Children’s Hospital Panel Reviews Cluster of Neurological Injuries After Intrathecal Chemotherapy

Patient Outcomes

KRAS Vaccine Elicits Durable Immune Response and Is Well Tolerated in High‑Risk Pancreatic Cohort

Selected Lung Transplants Linked to Higher One-Year Survival in Stage 4 Lung Cancer

ResMed Agrees to Sell MatrixCare to Frazier Healthcare Partners

Dual‑Mobility Hip Cups Cut Dislocation Risk by 70% in Large Randomized Trial

Can‑Fite Reports Safe Phase 2a Readout and Survival Signals for Namodenoson in Advanced Pancreatic Cancer

Resorbable‑Microsphere Embolization Cuts Knee Osteoarthritis Pain for a Year

Meta-Analysis Finds Tirzepatide Produces Largest Average Weight Loss Among FDA‑Approved GLP‑1s

Remote Monitoring Fails to Cut Readmissions After Sepsis and Raises Risk for Older Adults

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

Humacyte Prices $50 Million Stock Offering to Fund Symvess Push

Never miss stories about

Patient Outcomes

Employers and Insurers Pull Back Coverage for GLP‑1 Weight‑Loss Drugs

RCEM Links Nearly 16,000 Excess Deaths in England to Long A&E Waits

Roche Stops Phase 3 for Acmopatide After Positive Phase 2 in Type 1 Diabetes

Finerenone Slows Kidney Decline in Non‑Diabetic CKD, Trial Shows

UC Study Links Some Antibody‑Drug Conjugates to High Rates of Severe Neutropenia

Ivonescimab Extends Survival in China Phase 3 Trial for Squamous Lung Cancer

Erleada Plus Hormone Therapy Cuts Recurrence and Death in High‑Risk Localized Prostate Cancer

Implanted Cesium-131 Tiles Cut Recurrences and Boost Survival in ROADS Phase III Trial

NHS‑Backed Trial of Galleri Blood Test Fails to Meet Main Goal

Saitama Children’s Hospital Panel Reviews Cluster of Neurological Injuries After Intrathecal Chemotherapy

Never miss stories about

Patient Outcomes